Clinical Trials Browser

Not yet recruiting × Ovarian Neoplasms × Doxorubicin × Clear all

NCT06751485 2024-12-31

JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

Phase 3 Not yet recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms